Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 5
Results: 40
Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vitro antiproliferative and cytotoxic activities of novel triphenyltin isoselenocyanate in human breast carcinoma cell lines MCF 7 and MDA-MB-231.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Stereotactic body radiotherapy for spinal metastases: a review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ENO3 promotes colorectal cancer progression by enhancing cell glycolysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Photodynamic therapy using mannose-conjugated chlorin e6 increases cell surface calreticulin in cancer cells and promotes macrophage phagocytosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approaches.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: a case-control study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
KRT15 promotes colorectal cancer cell migration and invasion through β-catenin/MMP-7 signaling pathway.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi'an, China.
- Published in:
- 2022
- By:
- Publication type:
- Letter
DNA methylation marker to estimate ovarian cancer cell fraction.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01679-y
- By:
- Publication type:
- Article
Innovation in cancer therapeutics and regulatory perspectives.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01673-4
- By:
- Publication type:
- Article
Management of oligoprogression in non-small cell lung cancer patients.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01666-3
- By:
- Publication type:
- Article
In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01661-8
- By:
- Publication type:
- Article
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01660-9
- By:
- Publication type:
- Article
Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01657-4
- By:
- Publication type:
- Article
Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01655-6
- By:
- Publication type:
- Article
ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01654-7
- By:
- Publication type:
- Article
In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01651-w
- By:
- Publication type:
- Article
Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-022-01650-x
- By:
- Publication type:
- Article
Forward to a methodological proposal to support cancer patients: the dialogics' contribution for the precision care.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-021-01644-1
- By:
- Publication type:
- Article
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma.
- Published in:
- Medical Oncology, 2022, v. 39, n. 5, p. 1, doi. 10.1007/s12032-021-01632-5
- By:
- Publication type:
- Article